SCHEMBL4943540

SCHEMBL4943540

Cc1nc2c(C(=O)O)cnn2c(C)c1Cc1cccc(Cl)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 12/20 0.72
ALDH1A1 P00352 10/20 0.72
HPGD P15428 9/20 0.72
HSD17B10 Q99714 6/20 0.68
HTT P42858 3/20 0.67
LMNA P02545 9/20 0.66
MAPT P10636 4/20 0.66
TSHR P16473 3/20 0.66
MAPK1 P28482 2/20 0.66
USP2 O75604 2/20 0.66
SMN1; SMN2 Q16637 4/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
TP53 P04637 6/20 0.59
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
GAA P10253 1/20 0.55
MEN1 O00255 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15261476 0.90 KDM4E (0.60) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL4782331 0.89 HSD17B10 (0.74) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL4725435 0.89 HSD17B10 (0.70) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL4941774 0.87 HSD17B10 (0.83) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL4933302 0.87 HSD17B10 (0.68) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL4941861 0.87 KDM4E (0.81) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL4935332 0.86 HSD17B10 (0.82) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL4778302 0.85 HSD17B10 (0.73) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL4942505 0.85 KDM4E (0.63) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL4796367 0.85 KDM4E (0.63) KDM4EALDH1A1HPGDHSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221129-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221129-A1 New compounds SCD, SCD5, FASN KDM4E 3813/4885ALDH1A1 858/4885HPGD 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.